LVW Advisors’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
OAG
HL
DTC
LVW Advisors's GMAB Position: Q4 2024 in Review
LVW Advisors sold out of Genmab (GMAB) in Q4 2024, closing a stake of 12,333 shares — an estimated $301K sold.
LVW Advisors first reported a position in GMAB in Q3 2019 and held it in 21 quarters. The position peaked at $850K in Q3 2021. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.
- LVW Advisors reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
- LVW Advisors sold 12,333 Genmab shares in Q4 2024, an estimated $301K.
- LVW Advisors first reported a position in Genmab in Q3 2019 and held it in 21 quarters.
- LVW Advisors's Genmab position peaked at $850K in Q3 2021.
- 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.
Based on LVW Advisors's 13F filing for Q4 2024, filed 16 Jan 2025.